Procalcitonin as a Predictive Tool for Death and ICU Admission among Febrile Neutropenic Patients Visiting the Emergency Department

por Coyne, Christopher J., Castillo, Edward M., Shatsky, Rebecca A., Chan, Theodore C.
Publicado 2022

53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression

por Rothschild, Harriet, Jankowitz, Rachel, Shatsky, Rebecca, Mouabbi, Jason, Levine, Julia, Jo Chien, Alliance A
Publicado 2023

SDPS-47 CIRCULATING TUMOR CELL ANALYSIS FROM THE CEREBROSPINAL FLUID INFORMS EARLY DIAGNOSIS, TREATMENT AND PROGNOSIS IN LEPTOMENINGEAL CARCINOMATOSIS

por Sandri, Andrea, Bazhenov, Nadia, Orosco, Heather, Turpin, Tiffany, Shatsky, Rebecca, Schulte, Jessica, Piccioni, David
Publicado 2023

Comparison of Early- and Late-Stage Breast and Colorectal Cancer Diagnoses During vs Before the COVID-19 Pandemic

por Zhou, Jade Zifei, Kane, Shelly, Ramsey, Celia, Akhondzadeh, Melody, Banerjee, Ananya, Shatsky, Rebecca, Gold, Kathryn Ann
Publicado 2022

18F-FES PET/CT Improves the Detection of Intraorbital Metastases in Estrogen-Receptor-Positive Breast Cancer: Two Representative Cases and Review of the Literature

por Bodapati, Sandhya, Abraham, Peter, Chen, Angela, Guilbault, Denise, McDonald, Marin, Matro, Jennifer, Shatsky, Rebecca, Obrzut, Sebastian
Publicado 2022

Evaluating Cancer Pain Characteristics and Treatment Factors in the Emergency Department: A Retrospective Cohort Study

por Gupta, Rishi, Lin, Lucia, Resley, Vanessa, Khan, Ayesha, Li, David R., Shatsky, Rebecca A., Coyne, Christopher J.
Publicado 2022

53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression – CORRIGEND...

por Rothschild, Harriet T, Jo Chien, A, Jankowitz, Rachel C, Magbanua, Mark JM, Mouabbi, Jason A, Shatsky, Rebecca A, Levine, Julia, Mukhtar, Rita A
Publicado 2023

Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial

por Parker, Barbara A., Shatsky, Rebecca A., Schwab, Richard B., Wallace, Anne M., Wolf, Denise M., Hirst, Gillian L., Brown-Swigart, Lamorna, Esserman, Laura J., van ’t Veer, Laura J., Ghia, Emanuela M., Yau, Christina, Kipps, Thomas J.
Publicado 2023

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

por Kato, Shumei, Kim, Ki Hwan, Lim, Hyo Jeong, Boichard, Amelie, Nikanjam, Mina, Weihe, Elizabeth, Kuo, Dennis J., Eskander, Ramez N., Goodman, Aaron, Galanina, Natalie, Fanta, Paul T., Schwab, Richard B., Shatsky, Rebecca, Plaxe, Steven C., Sharabi, Andrew, Stites, Edward, Adashek, Jacob J., Okamura, Ryosuke, Lee, Suzanna, Lippman, Scott M., Sicklick, Jason K., Kurzrock, Razelle
Publicado 2020